zeffix
glaxosmithkline (ireland) limited - lamivudine - b hepatīts, hronisks - pretvīrusu līdzekļi sistēmiskai lietošanai - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. uzsākšanas lamivudīnu ārstēšanai, jāapsver tikai tad, kad izmantot alternatīvu pretvīrusu līdzeklis ar augstāku ģenētisko barjeru nav pieejami, vai arī ir nepieciešams;, decompensated aknu slimība kopā ar otro aģents, bez krusteniskās rezistences pret lamivudīnu.
revolade
novartis europharm limited - eltrombopags - purpura, trombocitopēnija, idiopātija - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 un 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 un 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
procto-glyvenol 400 mg/40 mg supozitoriji
recordati ireland limited, ireland - tribenosidum, lidocainum - supozitorijs - 400 mg/40 mg
betaloc zok 50 mg ilgstošās darbības tabletes
recordati industria chimica e farmaceutica s.p.a., italy - metoprolola sukcināts - ilgstošās darbības tablete - 50 mg
betaloc zok 100 mg ilgstošās darbības tabletes
recordati industria chimica e farmaceutica s.p.a., italy - metoprolola sukcināts - ilgstošās darbības tablete - 100 mg
larifans 2,5 mg/2 ml šķīdums injekcijām
larifāns, sia, latvia - ribonukleīnskābe, dubulta - Šķīdums injekcijām - 2,5 mg/2 ml
betaloc zok 100 mg ilgstošās darbības tabletes
recordati ireland limited, ireland - metoprolola sukcināts - ilgstošās darbības tablete - 100 mg
betaloc zok 25 mg ilgstošās darbības tabletes
recordati ireland limited, ireland - metoprolola sukcināts - ilgstošās darbības tablete - 25 mg
betaloc zok 50 mg ilgstošās darbības tabletes
recordati ireland limited, ireland - metoprolola sukcināts - ilgstošās darbības tablete - 50 mg
procto-glyvenol 50 mg/20 mg/g rektālais krēms
recordati ireland limited, ireland - tribenosidum, lidocaini hydrochloridum - rektālais krēms - 50 mg/20 mg/g